// App-Quantinova.ai

Su1927 : ETROLIZUMAB TREATMENT IMPROVES HISTOLOGICAL ACTIVITY AS ASSESSED BY THE ROBARTS HISTOPATHOLOGY INDEX

Researchers

Presenter

  • Gert De Hertogh

Principal Investigators

  • Laurent Peyrin-Biroulet

  • David T. Rubin

  • Romeo Maciuca

  • Jacqueline McBride

  • Udayasankar Arulmani

  • Alexis Scherl

Medical Centers

  • University of Western Ontario, London, ON, Canada

  • Rush University Medical Center, Chicago, Illinois, United States

  • University of Leuven, KUL, Leuven, Belgium

  • Universite de Lorraine, Vandoeuvre les Nancy, France

Locations

  • United States

  • Canada

  • France

  • Belgium

Companies

  • Genentech, Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Etrolizumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved